US Patent Issued to FARON PHARMACEUTICALS on July 29 for "Humanized anti clever-1 antibodies and their use" (Finnish Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,486, issued on July 29, was assigned to FARON PHARMACEUTICALS OY (Turku, Finland).

"Humanized anti clever-1 antibodies and their use" was invented by Mikael Maksimow (Turku, Finland), Markku Jalkanen (Piispanristi, Finland) and Marita Vainio (Turku, Finland).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to an agent and a humanized antibody or single chain Fv or Fab fragment capable of binding to human CLEVER-1 recognizing an epitope of CLEVER-1, wherein the epitope is discontinuous and comprises the sequences: PFTVLVPSVSSFSSR and QEITVTFNQFTK. This invention relates also an agent capable of binding to an epitope of human CLEVE...